Holen Sie sich die Stockscreener-App
5.3674
0.13%
-0.0026
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNKD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$5.37
Offen:
$5.39
24-Stunden-Volumen:
2.30M
Relative Volume:
0.58
Marktkapitalisierung:
$1.66B
Einnahmen:
$248.37M
Nettoeinkommen (Verlust:
$11.74M
KGV:
107.35
EPS:
0.05
Netto-Cashflow:
$18.24M
1W Leistung:
+0.62%
1M Leistung:
+16.84%
6M Leistung:
+8.34%
1J Leistung:
-14.33%
1-Tages-Spanne:
$5.33
$5.55
1-Wochen-Bereich:
$5.185
$5.62
52-Wochen-Spanne:
$3.3812
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Firmenname
Mannkind Corp
Sektor
Branche
Telefon
818-661-5000
Adresse
1 CASPER STREET, DANBURY, CA
Vergleichen Sie MNKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
5.405 | 1.65B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.64 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.96 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.86 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
773.12 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.13 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-02-10 | Eingeleitet | Wedbush | Outperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-10-10 | Eingeleitet | Wedbush | Outperform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-10-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2018-02-28 | Herabstufung | Maxim Group | Hold → Sell |
| 2017-11-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-10-06 | Bestätigt | Maxim Group | Buy |
| 2017-08-11 | Eingeleitet | Maxim Group | Buy |
| 2016-05-10 | Bestätigt | Piper Jaffray | Underweight |
| 2016-05-10 | Bestätigt | RBC Capital Mkts | Underperform |
| 2016-01-06 | Bestätigt | Piper Jaffray | Underweight |
| 2016-01-06 | Bestätigt | RBC Capital Mkts | Underperform |
| 2015-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Herabstufung | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-05-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Bestätigt | MLV & Co | Hold |
| 2015-04-16 | Bestätigt | RBC Capital Mkts | Outperform |
Alle ansehen
Mannkind Corp Aktie (MNKD) Neueste Nachrichten
Key metrics from MannKind Corporation’s quarterly dataCEO Change & Precise Entry and Exit Recommendations - newser.com
Is MannKind Corporation (NNFN) stock undervalued historicallyMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
Is MannKind Corporation a good long term investmentSector ETF Performance & Take Advantage of Momentum Stocks - earlytimes.in
MannKind (MNKD) Appoints New Chief Medical Officer - GuruFocus
MNKD Appoints New Chief Medical Officer to Strengthen Leadership Team - GuruFocus
MannKind appoints Ajay Ahuja as chief medical officer - Investing.com
MannKind Corporation Appoints Dr. Ajay Ahuja as Chief Medical Officer - Quiver Quantitative
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer - Yahoo Finance
Will MannKind Corporation (NNFN) stock see insider accumulationJuly 2025 Rallies & Stock Timing and Entry Methods - newser.com
Why MannKind Corporation (NNFN) stock is trending on social mediaEntry Point & High Accuracy Swing Trade Signals - newser.com
Will a bounce in MannKind Corporation offer an exitEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
Non Tuberculous Mycobacterial Infections Market Dynamics - openPR.com
MannKind (NASDAQ:MNKD) Shares Down 5%Time to Sell? - MarketBeat
MannKind (NASDAQ:MNKD) Earns Buy Rating from HC Wainwright - MarketBeat
MannKind Corporation (NASDAQ:MNKD) Sees Significant Drop in Short Interest - MarketBeat
Insider Selling: MannKind (NASDAQ:MNKD) Insider Sells 47,000 Shares of Stock - MarketBeat
Goldman Sachs Group Inc. Sells 780,939 Shares of MannKind Corporation $MNKD - MarketBeat
MannKind (NASDAQ:MNKD) Trading Down 4.2%Should You Sell? - MarketBeat
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock By Investing.com - Investing.com UK
Insider Sell Alert: Stuart Tross Sells 47,000 Shares of MannKind Corp (MNKD) - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock - Investing.com
Hedge Fund Bets: Can MannKind Corporation outperform under higher oil prices2025 Earnings Surprises & AI Powered Market Entry Strategies - خودرو بانک
Hedge Fund Moves: Can MannKind Corporation stock double in the next year2025 Performance Recap & Growth Focused Entry Reports - khodrobank.com
Can MannKind Corporation outperform in the next rallyQuarterly Risk Review & Verified Swing Trading Watchlist - خودرو بانک
Weekly Recap: What is MannKind Corporations P E ratio telling usQuarterly Investment Review & Consistent Return Strategy Ideas - خودرو بانک
Analyst Calls: Can MannKind Corporation navigate macro headwindsGold Moves & Consistent Profit Trading Strategies - خودرو بانک
Jacobs Levy Equity Management Inc. Increases Stock Holdings in MannKind Corporation $MNKD - MarketBeat
Millennium Management LLC Purchases 2,375,198 Shares of MannKind Corporation $MNKD - MarketBeat
Finanzdaten der Mannkind Corp-Aktie (MNKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):